The pathogenesis of coronary artery disease and the acute coronary syndromes (2).

IN the 19th century there were two major hypotheses to explain the pathogenesis of atherosclerosis: the "incrustation" hypothesis and the "lipid" hypothesis. The incrustation hypothesis of von Rokitansky,1 proposed in 1852 and modified by Duguid,2 suggested that intimal thickening resulted from fibrin deposition, with subsequent organization by fibroblasts and secondary lipid accumulation. The lipid hypothesis, proposed by Virchow3 in 1856, suggested that lipid in the arterial wall represented a transduction of blood lipid, which subsequently formed complexes with acid mucopolysaccharides; lipid accumulated in arterial walls because mechanisms of lipid deposition predominated over those of removal. The two hypotheses are now . . .

[1]  J J Albers,et al.  Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. , 1990, The New England journal of medicine.

[2]  F. Feit,et al.  Serial angiographic assessment of coronary artery obstruction and collateral flow in acute myocardial infarction. Report from the second Mount Sinai-New York University Reperfusion Trial. , 1989, Circulation.

[3]  D. Massel,et al.  Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. , 1990, The Journal of clinical investigation.

[4]  Steven E. Nissen,et al.  Intravascular Ultrasound Assessment of Lumen Size and Wall Morphology in Normal Subjects and Patients With Coronary Artery Disease , 1991, Circulation.

[5]  M. Lewis,et al.  Endothelium‐derived relaxing factor inhibits in vitro platelet aggregation , 1987, British journal of pharmacology.

[6]  R. Califf,et al.  Myocardial infarction with minimal coronary atherosclerosis in the era of thrombolytic reperfusion. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. , 1991, Journal of the American College of Cardiology.

[7]  F. Crea,et al.  Abnormal Vasomotor Changes Early After Coronary Angioplasty: A Quantitative Arteriographic Study of Their Time Course , 1991, Circulation.

[8]  S. Chierchia,et al.  Coronary vasospasm as a possible cause of myocardial infarction. A conclusion derived from the study of "preinfarction" angina. , 1978, The New England journal of medicine.

[9]  J. Thyberg,et al.  Regulation of differentiated properties and proliferation of arterial smooth muscle cells. , 1990, Arteriosclerosis.

[10]  J. Steinberg Book ReviewAmbulatory Pediatric Care , 1989 .

[11]  M. J. Mitchinson,et al.  MACROPHAGES AND ATHEROGENESIS , 1987, The Lancet.

[12]  M. Winniford,et al.  Speculation regarding mechanisms responsible for acute ischemic heart disease syndromes. , 1986, Journal of the American College of Cardiology.

[13]  H. Waldmann,et al.  Monocytic origin of foam cells in human atherosclerotic plaques. , 1984, Atherosclerosis.

[14]  V. Fuster,et al.  The Role of Collateral Circulation in the Various Coronary Syndromes , 1979, Circulation.

[15]  F. Bühler,et al.  Impact of smoking on heart attacks, strokes, blood pressure control, drug dose, and quality of life aspects in the International Prospective Primary Prevention Study in Hypertension. , 1988, American heart journal.

[16]  Louis E. Teichholz,et al.  Angiographie morphology and the pathogenesis of unstable angina pectoris , 1985 .

[17]  E. B. Smith,et al.  Fate of fibrinogen in human arterial intima. , 1990, Arteriosclerosis.

[18]  J. Badimón,et al.  Mechanisms of arterial thrombosis in nonparallel streamlines: platelet thrombi grow on the apex of stenotic severely injured vessel wall. Experimental study in the pig model. , 1989, The Journal of clinical investigation.

[19]  R. Ross The pathogenesis of atherosclerosis--an update. , 1986, The New England journal of medicine.

[20]  C. Benedict,et al.  Transcardiac serotonin concentration is increased in selected patients with limiting angina and complex coronary lesion morphology. , 1989, Circulation.

[21]  D. Ku,et al.  Hemodynamics and atherosclerosis. Insights and perspectives gained from studies of human arteries. , 1988, Archives of pathology & laboratory medicine.

[22]  J. Stamler,et al.  Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. , 1986, Journal of the American College of Cardiology.

[23]  R. Krauss,et al.  Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI , 1991, Nature.

[24]  A. Gown,et al.  Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. , 1986, The American journal of pathology.

[25]  A. Hassett,et al.  Plasminogen activator and plasminogen activator inhibitor activities in men with coronary artery disease. , 1989, The Journal of laboratory and clinical medicine.

[26]  N. Miller,et al.  Pathophysiology of reverse cholesterol transport. Insights from inherited disorders of lipoprotein metabolism. , 1989, Arteriosclerosis.

[27]  D. Steinberg,et al.  Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[28]  A. Maseri,et al.  Pre-existing coronary stenoses in patients with first myocardial infarction are not necessarily severe. , 1988, European heart journal.

[29]  J. Ordovás,et al.  Prevalence of familial hyperhomocyst(e)inemia in men with premature coronary artery disease. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[30]  G. V. R. Born,et al.  INFLUENCE OF PLAQUE CONFIGURATION AND STRESS DISTRIBUTION ON FISSURING OF CORONARY ATHEROSCLEROTIC PLAQUES , 1989, The Lancet.

[31]  R Gorlin,et al.  Determinants of collateral filling observed during sudden controlled coronary artery occlusion in human subjects. , 1989, Journal of the American College of Cardiology.

[32]  W. Willett,et al.  A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. , 1991, The New England journal of medicine.

[33]  V. Fuster,et al.  Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit. , 1990, The Journal of clinical investigation.

[34]  V. Fuster,et al.  Angiographic evolution of coronary artery morphology in unstable angina. , 1986, Journal of the American College of Cardiology.

[35]  L. Wilhelmsen,et al.  Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. , 1990, BMJ.

[36]  W. Daniel,et al.  Increased Thrombin Levels During Thrombolytic Therapy in Acute Myocardial Infarction: Relevance for the Success of Therapy , 1991, Circulation.

[37]  E. Falk Morphologic features of unstable atherothrombotic plaques underlying acute coronary syndromes. , 1989, The American journal of cardiology.

[38]  P. Rentrop,et al.  Selective Intracoronary Thrombolysis in Acute Myocardial Infarction and Unstable Angina Pectoris , 1981, Circulation.

[39]  W. Little,et al.  Angiographic assessment of the culprit coronary artery lesion before acute myocardial infarction. , 1990, The American journal of cardiology.

[40]  V. Fuster,et al.  Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. , 1990, Journal of the American College of Cardiology.

[41]  A. Yeung,et al.  The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. , 1991, The New England journal of medicine.

[42]  H V Anderson,et al.  Frequency and severity of cyclic flow alternations and platelet aggregation predict the severity of neointimal proliferation following experimental coronary stenosis and endothelial injury. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[43]  M. Reidy,et al.  Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF , 1991, Science.

[44]  R. Cotran,et al.  Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. , 1985, The Journal of clinical investigation.

[45]  N. Simionescu,et al.  Prelesional Modifications of the Vessel Wall in Hyperlipidemic Atherogenesis , 1990, Annals of the New York Academy of Sciences.

[46]  M S Golden,et al.  Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. , 1980, The New England journal of medicine.

[47]  V. Fuster,et al.  Is vasospasm related to platelet deposition? Relationship in a porcine preparation of arterial injury in vivo. , 1987, Circulation.

[48]  R. Bar-Shavit,et al.  Binding of thrombin to subendothelial extracellular matrix. Protection and expression of functional properties. , 1989, The Journal of clinical investigation.

[49]  M. Yanagisawa,et al.  INCREASED PLASMA CONCENTRATIONS OF ENDOTHELIN-1 AND BIG ENDOTHELIN-1 IN ACUTE MYOCARDIAL INFARCTION , 1989, The Lancet.

[50]  F. Zak,et al.  Morphodynamic Interpretation of Acute Coronary Thrombosis, with Special Reference to Volcano-Like Eruption of Atheromatous Plaque Caused by Coronary Artery Spasm , 1988, Angiology.

[51]  M. Reidy,et al.  Role of basic fibroblast growth factor in vascular lesion formation. , 1991, Circulation research.

[52]  R. Friedman,et al.  The effect of thrombocytopenia on experimental arteriosclerotic lesion formation in rabbits. Smooth muscle cell proliferation and re-endothelialization. , 1977, The Journal of clinical investigation.

[53]  V. Fuster,et al.  Morphologic and dynamic changes of atherosclerotic plaque at the carotid artery bifurcation: sequential imaging by real time B-mode ultrasonography. , 1988, Journal of the American College of Cardiology.

[54]  J. Vane,et al.  Regulatory functions of the vascular endothelium. , 1990, The New England journal of medicine.

[55]  G. Dahlén,et al.  Evidence for increased levels of plasminogen activator inhibitor and tissue plasminogen activator in plasma of patients with angiographically verified coronary artery disease. , 1989, European heart journal.

[56]  R D Fish,et al.  Loss of Flow‐Mediated Endothelium‐Dependent Dilation Occurs Early in the Development of Atherosclerosis , 1991, Circulation.

[57]  L. Wilhelmsen,et al.  Fibrinogen as a risk factor for stroke and myocardial infarction. , 1984, The New England journal of medicine.

[58]  G. Bondjers,et al.  Regional Accumulations of T Cells, Macrophages, and Smooth Muscle Cells in the Human Atherosclerotic Plaque , 1986, Arteriosclerosis.

[59]  V. Fuster,et al.  An acute surge of epinephrine stimulates platelet deposition to severely damaged vascular wall , 1990 .

[60]  M. Territo,et al.  Monocyte Chemotactic Factor Produced by Large Vessel Endothelial Cells in Vitro , 1986, Arteriosclerosis.

[61]  L. V. von Segesser,et al.  Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries. A new mechanism of vasospasm? , 1990, Circulation.

[62]  J. Vane,et al.  An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation , 1976, Nature.

[63]  J. Cullen,et al.  International control of smoking and the US experience. , 1986, Chest.

[64]  H. Drexler,et al.  Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. , 1991, Circulation.

[65]  D. Hathaway,et al.  Molecular cardiology: new avenues for the diagnosis and treatment of cardiovascular disease. , 1989, Journal of the American College of Cardiology.

[66]  T. Drake,et al.  Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. , 1989, The American journal of pathology.

[67]  B. G. Brown,et al.  Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI Investigators. , 1991, Circulation.

[68]  S. Chierchia,et al.  Intermittent coronary occlusion in acute myocardial infarction. Value of combined thrombolytic and vasodilator therapy. , 1987, The New England journal of medicine.

[69]  W. Roberts,et al.  The frequency and significance of coronary arterial thrombi and other observations in fatal acute myocardial infarction: a study of 107 necropsy patients. , 1972, The American journal of medicine.

[70]  J. Breslow,et al.  Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis , 1989, Nature.

[71]  M. Nobuyoshi,et al.  Progression of coronary atherosclerosis: is coronary spasm related to progression? , 1991, Journal of the American College of Cardiology.

[72]  S. Willich,et al.  Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. , 1987, The New England journal of medicine.

[73]  C. Francis,et al.  Thrombin activity of fibrin thrombi and soluble plasmic derivatives. , 1983, The Journal of laboratory and clinical medicine.

[74]  W. F. Fulton,et al.  The coronary arteries : Arteriography, microanatomy, and pathogenesis of obliterative coronary artery disease , 1965 .

[75]  E. Braunwald,et al.  Unstable angina. A classification. , 1989, Circulation.

[76]  A. J. Valente,et al.  Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture. , 1988, Biochemistry.

[77]  S. Thompson,et al.  HÆMOSTATIC FUNCTION AND CARDIOVASCULAR DEATH: EARLY RESULTS OF A PROSPECTIVE STUDY , 1980, The Lancet.

[78]  A. Angelini,et al.  Factors influencing the presence or absence of acute coronary artery thrombi in sudden ischaemic death. , 1989, European heart journal.

[79]  S. Davies,et al.  Irregular coronary lesion morphology after thrombolysis predicts early clinical instability. , 1991, Journal of the American College of Cardiology.

[80]  H. Goldsmith,et al.  Flow Patterns in Vessels of Simple and Complex Geometries a , 1987, Annals of the New York Academy of Sciences.

[81]  J. Loscalzo,et al.  Lipoprotein(a). A unique risk factor for atherothrombotic disease. , 1990, Arteriosclerosis.

[82]  O. Paul Background of the Prevention of Cardiovascular Disease: II. Arteriosclerosis, Hypertension, and Selected Risk Factors , 1989, Circulation.

[83]  V. Fuster,et al.  Arteriosclerosis in Normal and von Willebrand Pigs: Long‐Term Prospective Study and Aortic Transplantation Study , 1982, Circulation research.

[84]  G. FitzGerald,et al.  Role of thrombin and thromboxane A2 in reocclusion following coronary thrombolysis with tissue-type plasminogen activator. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[85]  F. España,et al.  Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease. , 1988, British heart journal.

[86]  R. Califf,et al.  Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group. , 1990, Circulation.

[87]  L. Hillis,et al.  Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. , 1981, The New England journal of medicine.

[88]  White Hd GISSI-2 and the heparin controversy. , 1990 .

[89]  L Morgenstern,et al.  Coronary angioscopy in patients with unstable angina pectoris. , 1986, The New England journal of medicine.

[90]  R Gorlin,et al.  Angiographic demonstration of a common link between unstable angina pectoris and non-Q-wave acute myocardial infarction. , 1988, The American journal of cardiology.

[91]  W. Roberts,et al.  Morphologic comparison of frequency and types of acute lesions in the major epicardial coronary arteries in unstable angina pectoris, sudden coronary death and acute myocardial infarction. , 1991, Journal of the American College of Cardiology.

[92]  J P Matts,et al.  Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH) , 1990, The New England journal of medicine.

[93]  J Pekkanen,et al.  Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. , 1990, The New England journal of medicine.

[94]  G. Boers,et al.  Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. , 1985, The New England journal of medicine.

[95]  K. Griendling,et al.  Thrombin signal transduction mechanisms in rat vascular smooth muscle cells. Calcium and protein kinase C-dependent and -independent pathways. , 1990, The Journal of biological chemistry.

[96]  R. Furchgott,et al.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.

[97]  K. Pritchard,et al.  Native low density lipoprotein. Endothelial cell recruitment of mononuclear cells. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[98]  J. Huttunen,et al.  Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. , 1987, The New England journal of medicine.

[99]  P. Libby,et al.  Production of platelet-derived growth factor-like mitogen by smooth-muscle cells from human atheroma. , 1988, The New England journal of medicine.

[100]  A. Barger,et al.  Rupture of coronary vasa vasorum as a trigger of acute myocardial infarction. , 1990, The American journal of cardiology.

[101]  P. Constantinides,et al.  Plaque fissures in human coronary thrombosis , 1966 .

[102]  V. Fuster,et al.  Effect of balloon inflation on smooth muscle cell proliferation in the porcine carotid artery , 1990 .

[103]  P. Cohen,et al.  Platelets and atherogenesis , 1968 .

[104]  M. Reidy,et al.  Regulation of Smooth Muscle Cell Growth in Injured Artery , 1989, Journal of cardiovascular pharmacology.

[105]  J L Witztum,et al.  Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. , 1989, The Journal of clinical investigation.

[106]  R M Nerem,et al.  The pathogenesis of atherosclerosis: An overview , 1991, Clinical cardiology.

[107]  G. Hutchins,et al.  The relationship between coronary artery lesions and myocardial infarcts: ulceration of atherosclerotic plaques precipitating coronary thrombosis. , 1977, American heart journal.

[108]  S. Willich,et al.  Increased morning incidence of myocardial infarction in the ISAM Study: absence with prior beta-adrenergic blockade. ISAM Study Group. , 1989, Circulation.

[109]  V. Fuster,et al.  Balloon angioplasty. Natural history of the pathophysiological response to injury in a pig model. , 1985, Circulation research.

[110]  V. Fuster,et al.  Angiographic progression of coronary artery disease and the development of myocardial infarction. , 1988, Journal of the American College of Cardiology.

[111]  D. Steinberg Antioxidants and atherosclerosis. A current assessment. , 1991, Circulation.

[112]  D. Gordon,et al.  High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. , 1989, Circulation.

[113]  M. Yanagisawa,et al.  Increased plasma level of endothelin-1 and coronary spasm induction in patients with vasospastic angina pectoris. , 1991, Circulation.

[114]  J. Eidt,et al.  Specific Platelet Mediators and Unstable Coronary Artery Lesions: Experimental Evidence and Potential Clinical Implications , 1989, Circulation.

[115]  V. Fuster,et al.  Resistance to arteriosclerosis in pigs with von Willebrand's disease. Spontaneous and high cholesterol diet-induced arteriosclerosis. , 1978, The Journal of clinical investigation.

[116]  D C Levin,et al.  Significance of the Angiographic Morphology of Localized Coronary Stenoses: Histopathologic Correlations , 1982, Circulation.

[117]  W. Santamore,et al.  Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? , 1988, Circulation.

[118]  S. Vallabhajosula,et al.  Dynamic monitoring of platelet deposition on severely damaged vessel wall in flowing blood. Effects of different stenoses on thrombus growth. , 1990, Arteriosclerosis.

[119]  M. Reidy,et al.  Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[120]  K. Zitnay,et al.  Loss of Selective Endothelial Cell Vasoactive Functions Caused by Hypercholesterolemia in Pig Coronary Arteries , 1988, Circulation research.

[121]  R. D'Agostino,et al.  Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study. , 1987, American heart journal.

[122]  J. Newhouse,et al.  Are We Training Too Many Subspecialists?-Reply , 1988 .

[123]  K. Gould,et al.  Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial , 1990, The Lancet.

[124]  R. W. Brower,et al.  Effect of continued rt-PA administration on the residual stenosis after initially successful recanalization in acute myocardial infarction--a quantitative coronary angiography study of a randomized trial. , 1987, European heart journal.

[125]  G. FitzGerald,et al.  Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction. , 1988, Circulation.

[126]  R. Detrano,et al.  The dynamics of progression of coronary atherosclerosis studied in 168 medically treated patients who underwent coronary arteriography three times. , 1989, American heart journal.

[127]  M. Winniford,et al.  Smoking-induced coronary vasoconstriction in patients with atherosclerotic coronary artery disease: evidence for adrenergically mediated alterations in coronary artery tone. , 1986, Circulation.

[128]  V. Fuster,et al.  Insights into the pathogenesis of acute ischemic syndromes. , 1988, Circulation.

[129]  L. Wilhelmsen,et al.  Social influences and cardiovascular risk factors as determinants of plasma fibrinogen concentration in a general population sample of middle aged men. , 1990, BMJ.

[130]  V. Fuster,et al.  High density lipoprotein plasma fractions inhibit aortic fatty streaks in cholesterol-fed rabbits. , 1989, Laboratory investigation; a journal of technical methods and pathology.

[131]  B. Hunt The relation between abnormal hemostatic function and the progression of coronary disease , 1990 .

[132]  R. Mesa-Tejada,et al.  Identification and Distribution of Fibrinogen, Fibrin, and Fibrin(ogen) Products in Atherosclerosis: Use of Monoclonal Antibodies , 1989, Arteriosclerosis.

[133]  T. P. Judge,et al.  Coronary arteriographic findings soon after non-Q-wave myocardial infarction. , 1986, The New England journal of medicine.

[134]  V. Fuster,et al.  Platelet deposition at high shear rates is enhanced by high plasma cholesterol levels. In vivo study in the rabbit model. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[135]  H. Shimokawa,et al.  Endothelium‐Derived Relaxing Factor and Coronary Vasospasm , 1989, Circulation.

[136]  C. Zarins,et al.  Compensatory enlargement of human atherosclerotic coronary arteries. , 1987, The New England journal of medicine.

[137]  R. Kerber,et al.  Delineation of the extent of coronary atherosclerosis by high-frequency epicardial echocardiography. , 1987, The New England journal of medicine.

[138]  E. Veys,et al.  HL-A AND INFECTIVE SACROILEITIS , 1974 .

[139]  F. Van de Werf,et al.  Angiographic assessment of the infarct-related residual coronary stenosis after spontaneous or therapeutic thrombolysis. , 1990, Journal of the American College of Cardiology.

[140]  A. Gotto,et al.  CORONARY ARTERY DISEASE Association of levels of lipoprotein Lp ( a ) , plasma lipids , and other lipoproteins with coronary artery disease documented by angiography , 2022 .

[141]  A. Jaffe,et al.  Paradoxic elevation of fibrinopeptide A after streptokinase: evidence for continued thrombosis despite intense fibrinolysis. , 1987, Journal of the American College of Cardiology.

[142]  M. Bourassa,et al.  Clinical and angiographic predictors of new total coronary occlusion in coronary artery disease: analysis of 313 nonoperated patients. , 1984, The American journal of cardiology.

[143]  E L Bolson,et al.  Incomplete lysis of thrombus in the moderate underlying atherosclerotic lesion during intracoronary infusion of streptokinase for acute myocardial infarction: quantitative angiographic observations. , 1986, Circulation.

[144]  E. Chen,et al.  cDNA sequence of human apolipoprotein(a) is homologous to plasminogen , 1987, Nature.

[145]  M. Yacoub,et al.  Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries , 1990, The Lancet.

[146]  A. Maseri,et al.  Coronary constriction in acute myocardial infarction: role of nitrates. , 1988, European heart journal.

[147]  L. Guize,et al.  Factor VII activation and menopausal status. , 1990, Thrombosis research.

[148]  E. Falk Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. , 1985, Circulation.

[149]  M. Blombäck,et al.  PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION , 1987, The Lancet.

[150]  Sadao Kimura,et al.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells , 1988, Nature.

[151]  S. Davies,et al.  Coronary lesion morphology in acute myocardial infarction: demonstration of early remodeling after streptokinase treatment. , 1990, Journal of the American College of Cardiology.

[152]  D. McGill,et al.  The relationship between blood fibrinogen level and coronary artery disease , 1990 .

[153]  M. Friedman,et al.  The pathogenesis of a coronary thrombus. , 1966, The American journal of pathology.

[154]  J. Pepper,et al.  Morphology of the endothelium over atherosclerotic plaques in human coronary arteries. , 1988, British heart journal.

[155]  R. Ross,et al.  Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. , 1976, The Journal of clinical investigation.

[156]  B. Gordon,et al.  Plasmin catalyzes binding of lipoprotein (a) to immobilized fibrinogen and fibrin. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[157]  E. Boerwinkle,et al.  Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. , 1990, The New England journal of medicine.

[158]  M. Brown,et al.  Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. , 1983, Annual review of biochemistry.

[159]  V. Fuster,et al.  Platelet Survival and the Development of Coronary Artery Disease in the Young Adult: Effects of Cigarette Smoking, Strong Family History and Medical Therapy , 1981, Circulation.

[160]  Y. Yazaki,et al.  Endothelin stimulates c‐fos and c‐myc expression and proliferation of vascular smooth muscle cells , 1988, FEBS letters.

[161]  J. B. Duguid Thrombosis as a factor in the pathogenesis of coronary atherosclerosis. , 1946, The Journal of pathology and bacteriology.

[162]  Kathleen M. Smith,et al.  Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. , 1988, The Journal of clinical investigation.

[163]  P. Serruys,et al.  Angina pectoris. What will be the requirements for acute interventional procedures in Europe? , 1987, European heart journal.

[164]  H. Araki,et al.  Effects of thrombosis on vascular tone in rat mesenteric arteries with endothelium in vivo. , 1990, Circulation research.

[165]  N. Wolf,et al.  Frequency of intracoronary filling defects by angiography in angina pectoris at rest. , 1985, The American journal of cardiology.

[166]  E. Braunwald,et al.  Circadian variation in the frequency of onset of acute myocardial infarction. , 1985, The New England journal of medicine.

[167]  S. Moncada,et al.  Vascular endothelial cells synthesize nitric oxide from L-arginine , 1988, Nature.

[168]  J. Guyton,et al.  Ultrastructure of the human aortic fibrolipid lesion. Formation of the atherosclerotic lipid-rich core. , 1986, The American journal of pathology.

[169]  L Roy,et al.  Platelet activation in unstable coronary disease. , 1986, The New England journal of medicine.

[170]  M. Stadius,et al.  Coronary artery vasoconstriction routinely occurs after percutaneous transluminal coronary angioplasty. A quantitative arteriographic analysis. , 1988, Circulation.

[171]  M. Freeman,et al.  Type I macrophage scavenger receptor contains α-helical and collagen-like coiled coils , 1990, Nature.

[172]  T. Wight,et al.  Cell biology of arterial proteoglycans. , 1989, Arteriosclerosis.

[173]  V. Fuster,et al.  Platelet thrombus formation on collagen type I. A model of deep vessel injury. Influence of blood rheology, von Willebrand factor, and blood coagulation. , 1988, Circulation.

[174]  Kathleen M. Smith,et al.  Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[175]  A. M. Lefer,et al.  Cardiovascular effects of acute hypercholesterolemia in rabbits. Reversal with lovastatin treatment. , 1989, The Journal of clinical investigation.

[176]  P. Ganz,et al.  Early evidence of endothelial vasodilator dysfunction at coronary branch points. , 1990, Circulation.

[177]  R. Collins,et al.  Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease. , 1989, Circulation.

[178]  L. Romics,et al.  Lipoprotein (a) and plasminogen are immunochemically related. , 1988, Biochimica et biophysica acta.

[179]  K. Friedman,et al.  Thrombolytic therapy with tissue plasminogen activator or streptokinase induces transient thrombin activity. , 1988, Blood.